A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars
Clinical trial NCT00825916 · COMPLETED
Trial details
- NCT number
- NCT00825916
- Sponsor
- Capstone Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-07-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.